| Application no. and date | 18740615.2 (espacenet) (Federated) (European Patent Register), 20180723 | | Patent/reg. no. and date | DK/EP 3658147, 20211110 | | Publication date | 20200603 | | Priority no. and date | US 201762536121 P, 20170724, EP 17305998, 20170725 | | EP pub. no. and date |
EP 3658147 20200603 | | Effective date | | | Applicant/owner | Sanofi, 46 Avenue de la Grande Armée
75017 Paris, FR | | Applicant ref. no. | 1621190 | | Inventor | BOUABOULA, Monsif, c/o Sanofi
Patent Department
54 rue La Boétie
75008 Paris, FR,
SHOMALI, Maysoun, c/o Sanofi
Patent Department
55 Corporate Drive
Mail Code: 55A-505A
Bridgewater, New Jersey 08807, US,
SUN, Fangxian, c/o Sanofi
Patent Department
55 Corporate Drive
Mail Code: 55A-505A
Bridgewater, New Jersey 08807, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/40 (2006.01) , A61K 31/519 (2006.01) , A61P 35/00 (2006.01) | | Title | KOMBINATION, SOM OMFATTER PALBOCICLIB OG 6-(2,4-DICHLORPHENYL)-5-[4-[(3S)-1-(3-FLUORPROPYL)PYRROLIDIN-3-YL]OXYPHENYL]-8,9-DIHYDRO-7H-BENZO[7]ANNULEN-2-CARBOXYLSYRE, OG DENS ANVENDELSE TIL BEHANDLING AF CANCER | | Int. application no. | EP2018069901 | | Int. publication no. | WO2019020559 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
